Citrate-based biomaterial aids bone regeneration in first patient surgery

A novel citrate-based biomaterial has been used in its first patient surgery to regenerate bone tissue. The technology, called Citregraft, is a synthetic bone graft substitute that supports bone regeneration by binding growth factors and releasing citrate before being replaced by natural bone. This marks a significant milestone for regenerative engineering, building on two decades of research and collaboration with Acuitive Technologies.